Fresenius Kabi

• NCT04019184

  Collaborator, Phase 3, Completed, 64 people, 15 Jul 2019

• NCT03846102

  Collaborator, Phase 4, Terminated, 55 people, 19 Feb 2019

• NCT03666546

  Phase 4, Completed, 24 people, 12 Sept 2018

• NCT02795039

  Phase 1, Completed, 266 people, 9 Jun 2016

• NCT01856998

  Phase 3, Completed, 71 people, 20 May 2013

• NCT01565278

  Collaborator, Phase 3, Terminated, 2 people, 28 Mar 2012

• NCT01552291

  Collaborator, Phase 4, Completed, 42 people, 13 Mar 2012

• NCT00515736

  Collaborator, Phase 3, Terminated, 200 people, 14 Aug 2007

• Normative Reference Values and Cut-Off Points for Nutritional Ultrasound: The VALORES Study

  C24051, 1 Aug 2026

Sources: api.crossref.org

• Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease: The NOPARK Randomized Clinical Trial

  Fees or honoraria, 8 Oct 2026

• An integrated lifestyle intervention for mitigation of adverse effects associated with androgen deprivation therapy for prostate cancer (STAMINA): a multicentre, randomised trial

  Consulting or advice, Fees or honoraria, 4 Sept 2026

• Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer

  Fees or honoraria, 1 Sept 2026

• Achieved systolic blood pressure and cardiovascular outcomes in advanced chronic kidney disease

  Fees or honoraria, 31 Aug 2026

• Incidence, time trends and predictors of acute kidney injury in the region of Stockholm, Sweden

  Fees or honoraria, 15 Aug 2026

• Obesity and Women's health across the lifespan: A clinical review of life Stage-Specific challenges and treatment considerations

  Consulting or advice, 14 Aug 2026

• Premature and early menopause and neuroimaging biomarkers of neurodegenerative diseases: a systematic review

  Consulting or advice, 12 Aug 2026

• Association between rheumatoid arthritis, frailty status, mortality and anti-cancer therapy: a retrospective SEER-Medicare analysis in patients with non-metastatic renal cell carcinoma

  Consulting or advice, 11 Aug 2026

• Optimizing mini nutritional assessment as a prognostic tool in oncology: evidence from 50 hospitals

  Fees or honoraria, 5 Aug 2026

• Impact of FRAXplus adjustments vs FRAX on fracture risk classification in the Swiss Osteoporosis Registry

  Consulting or advice, Fees or honoraria, Grants or research support, 28 Jul 2026

• The "Reducing Inflammation for Greater Health Trial (RIGHT)" Study-Concept, Rationale, and Design

  Fees or honoraria, Grants or research support, 10 Jan 2026

• Sarcopenia and Sarcopenic Obesity and Mortality Among Older People

  Fees or honoraria, 4 Mar 2024

• Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging

  Consulting or advice, Fees or honoraria, Board or leadership role, 1 Jul 2023

Sources: pubmed.ncbi.nlm.nih.gov